BioCentury
ARTICLE | Company News

Novartis cardiovascular news

October 21, 2013 7:00 AM UTC

An interim report released by Japan's Ministry of Health, Labor and Welfare (MHLW) found that Novartis may have violated Japanese law by promoting hypertension drug Diovan valsartan as a treatment fo...